NCT04505553View on ClinicalTrials.gov

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 7, 2024

Study Completion Date

March 31, 2024

Conditions
Appendix CarcinomaColon CarcinomaEsophageal CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct CarcinomaMalignant Digestive System NeoplasmPancreatic CarcinomaRectal CarcinomaSmall Intestinal CarcinomaAnal CarcinomaDigestive System CarcinomaDigestive System Neuroendocrine TumorPancreatic Neuroendocrine Tumor
Interventions
PROCEDURE

Acupuncture Therapy

Undergo acupuncture

PROCEDURE

Acupressure Therapy

Undergo acupressure

PROCEDURE

Oral Cryotherapy

Undergo oral cryotherapy

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

The Safeway Foundation

UNKNOWN

lead

University of Washington

OTHER